Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 19

1.

The Impact of Moving from EQ-5D-3L to -5L in NICE Technology Appraisals.

Pennington B, Hernandez-Alava M, Pudney S, Wailoo A.

Pharmacoeconomics. 2018 Aug 9. doi: 10.1007/s40273-018-0701-y. [Epub ahead of print]

PMID:
30094806
2.

Development of Methods for the Mapping of Utilities Using Mixture Models: Mapping the AQLQ-S to the EQ-5D-5L and the HUI3 in Patients with Asthma.

Gray LA, Hernández Alava M, Wailoo AJ.

Value Health. 2018 Jun;21(6):748-757. doi: 10.1016/j.jval.2017.09.017. Epub 2017 Dec 14.

3.

Family lifestyle dynamics and childhood obesity: evidence from the millennium cohort study.

Gray LA, Hernandez Alava M, Kelly MP, Campbell MJ.

BMC Public Health. 2018 Apr 16;18(1):500. doi: 10.1186/s12889-018-5398-5.

4.

EQ-5D-5L versus EQ-5D-3L: The Impact on Cost Effectiveness in the United Kingdom.

Hernandez Alava M, Wailoo A, Grimm S, Pudney S, Gomes M, Sadique Z, Meads D, O'Dwyer J, Barton G, Irvine L.

Value Health. 2018 Jan;21(1):49-56. doi: 10.1016/j.jval.2017.09.004. Epub 2017 Oct 18.

PMID:
29304940
5.

Econometric modelling of multiple self-reports of health states: The switch from EQ-5D-3L to EQ-5D-5L in evaluating drug therapies for rheumatoid arthritis.

Hernández-Alava M, Pudney S.

J Health Econ. 2017 Sep;55:139-152. doi: 10.1016/j.jhealeco.2017.06.013. Epub 2017 Jul 4.

6.

Predicting Productivity Losses from Health-Related Quality of Life Using Patient Data.

Mukuria C, Rowen D, Hernández-Alava M, Dixon S, Ara R.

Appl Health Econ Health Policy. 2017 Oct;15(5):597-614. doi: 10.1007/s40258-017-0326-x.

7.

Children's Development and Parental Input: Evidence From the UK Millennium Cohort Study.

Hernández-Alava M, Popli G.

Demography. 2017 Apr;54(2):485-511. doi: 10.1007/s13524-017-0554-6.

8.

Mapping to Estimate Health-State Utility from Non-Preference-Based Outcome Measures: An ISPOR Good Practices for Outcomes Research Task Force Report.

Wailoo AJ, Hernandez-Alava M, Manca A, Mejia A, Ray J, Crawford B, Botteman M, Busschbach J.

Value Health. 2017 Jan;20(1):18-27. doi: 10.1016/j.jval.2016.11.006. Erratum in: Value Health. 2017 Sep;20(8):1226.

9.

The Cost-effectiveness of Sequences of Biological Disease-modifying Antirheumatic Drug Treatment in England for Patients with Rheumatoid Arthritis Who Can Tolerate Methotrexate.

Stevenson MD, Wailoo AJ, Tosh JC, Hernandez-Alava M, Gibson LA, Stevens JW, Archer RJ, Simpson EL, Hock ES, Young A, Scott DL.

J Rheumatol. 2017 Jul;44(7):973-980. doi: 10.3899/jrheum.160941. Epub 2017 Feb 15. Review.

10.
11.

The effects of breastfeeding on childhood BMI: a propensity score matching approach.

Gibson LA, Hernández Alava M, Kelly MP, Campbell MJ.

J Public Health (Oxf). 2017 Dec 1;39(4):e152-e160. doi: 10.1093/pubmed/fdw093.

12.
13.

Estimating informal care inputs associated with EQ-5D for use in economic evaluation.

Rowen D, Dixon S, Hernández-Alava M, Mukuria C.

Eur J Health Econ. 2016 Jul;17(6):733-44. doi: 10.1007/s10198-015-0718-5. Epub 2015 Aug 15.

14.

Cost-effectiveness of treatment strategies using combination disease-modifying anti-rheumatic drugs and glucocorticoids in early rheumatoid arthritis.

Wailoo A, Hernández Alava M, Scott IC, Ibrahim F, Scott DL.

Rheumatology (Oxford). 2014 Oct;53(10):1773-7. doi: 10.1093/rheumatology/keu039. Epub 2014 Apr 25.

PMID:
24771112
15.

Modelling the relationship between the WOMAC Osteoarthritis Index and EQ-5D.

Wailoo A, Hernandez Alava M, Escobar Martinez A.

Health Qual Life Outcomes. 2014 Mar 12;12:37. doi: 10.1186/1477-7525-12-37.

16.

Use of generic and condition-specific measures of health-related quality of life in NICE decision-making: a systematic review, statistical modelling and survey.

Longworth L, Yang Y, Young T, Mulhern B, Hernández Alava M, Mukuria C, Rowen D, Tosh J, Tsuchiya A, Evans P, Devianee Keetharuth A, Brazier J.

Health Technol Assess. 2014 Feb;18(9):1-224. doi: 10.3310/hta18090. Review.

17.

A comparison of direct and indirect methods for the estimation of health utilities from clinical outcomes.

Hernández Alava M, Wailoo A, Wolfe F, Michaud K.

Med Decis Making. 2014 Oct;34(7):919-30. doi: 10.1177/0272989X13500720. Epub 2013 Sep 11.

PMID:
24025662
18.

The relationship between EQ-5D, HAQ and pain in patients with rheumatoid arthritis.

Hernández Alava M, Wailoo A, Wolfe F, Michaud K.

Rheumatology (Oxford). 2013 May;52(5):944-50. doi: 10.1093/rheumatology/kes400. Epub 2013 Jan 21.

19.

Tails from the peak district: adjusted limited dependent variable mixture models of EQ-5D questionnaire health state utility values.

Hernández Alava M, Wailoo AJ, Ara R.

Value Health. 2012 May;15(3):550-61. doi: 10.1016/j.jval.2011.12.014. Epub 2012 Mar 23.

Supplemental Content

Loading ...
Support Center